Evaluation of Angiogenesis in Acute Leukemia Patients

Volume: 29 Number: 2 June 1, 2003
  • Tülay Özçelik
  • Rıdvan Ali
  • Fahir Özkalemkaş
  • Vildan Özkocaman
  • Ülkü Ozan
  • Hülya Öztürk
  • Ahmet Tunalı
EN TR

Evaluation of Angiogenesis in Acute Leukemia Patients

Abstract

The importance of angiogenesis for solid tumors is well established. In contrast only few data are available for hematologic neoplasms. In our study we aimed to investigate the role of angiogenesis in bone marrow biopsies of untreated acute leukemia patients. Microvessel counts in the bone marrow biopsies of untreated patients were compared with normal controls and with ones counted at the time of complete remission. Thirteen patients were included in the study. Bone marrow samples were immunohistochemically stained with von Willebrand factor. Microvessels were scored in two areas of the highest microvessel density in sections of each bone marrow specimen. Angiogenesis was expressed as the number of vessels counted at x400 magnification. Bone marrow microvessel count was significantly increased in acute leukemia patients compared with controls (p<0,01). Additionally microvessel count at presentation was significantly higher than the one assassed at the time of complete remission (p<0,01). In conclusion by demonstrating increased angiogenesis in the bone marrow of acute leukemia patients we think that angiogenesis may play a role in the pathophysiology of acute leukemia.

Keywords

Details

Primary Language

English

Subjects

-

Journal Section

-

Authors

Tülay Özçelik This is me

Rıdvan Ali This is me

Fahir Özkalemkaş This is me

Vildan Özkocaman This is me

Ülkü Ozan This is me

Hülya Öztürk This is me

Ahmet Tunalı This is me

Publication Date

June 1, 2003

Submission Date

June 1, 2003

Acceptance Date

-

Published in Issue

Year 2003 Volume: 29 Number: 2

APA
Özçelik, T., Ali, R., Özkalemkaş, F., Özkocaman, V., Ozan, Ü., Öztürk, H., & Tunalı, A. (2003). Evaluation of Angiogenesis in Acute Leukemia Patients. Journal of Uludağ University Medical Faculty, 29(2), 1-6. https://izlik.org/JA26UB53UY
AMA
1.Özçelik T, Ali R, Özkalemkaş F, et al. Evaluation of Angiogenesis in Acute Leukemia Patients. Journal of Uludağ University Medical Faculty. 2003;29(2):1-6. https://izlik.org/JA26UB53UY
Chicago
Özçelik, Tülay, Rıdvan Ali, Fahir Özkalemkaş, et al. 2003. “Evaluation of Angiogenesis in Acute Leukemia Patients”. Journal of Uludağ University Medical Faculty 29 (2): 1-6. https://izlik.org/JA26UB53UY.
EndNote
Özçelik T, Ali R, Özkalemkaş F, Özkocaman V, Ozan Ü, Öztürk H, Tunalı A (June 1, 2003) Evaluation of Angiogenesis in Acute Leukemia Patients. Journal of Uludağ University Medical Faculty 29 2 1–6.
IEEE
[1]T. Özçelik et al., “Evaluation of Angiogenesis in Acute Leukemia Patients”, Journal of Uludağ University Medical Faculty, vol. 29, no. 2, pp. 1–6, June 2003, [Online]. Available: https://izlik.org/JA26UB53UY
ISNAD
Özçelik, Tülay - Ali, Rıdvan - Özkalemkaş, Fahir - Özkocaman, Vildan - Ozan, Ülkü - Öztürk, Hülya - Tunalı, Ahmet. “Evaluation of Angiogenesis in Acute Leukemia Patients”. Journal of Uludağ University Medical Faculty 29/2 (June 1, 2003): 1-6. https://izlik.org/JA26UB53UY.
JAMA
1.Özçelik T, Ali R, Özkalemkaş F, Özkocaman V, Ozan Ü, Öztürk H, Tunalı A. Evaluation of Angiogenesis in Acute Leukemia Patients. Journal of Uludağ University Medical Faculty. 2003;29:1–6.
MLA
Özçelik, Tülay, et al. “Evaluation of Angiogenesis in Acute Leukemia Patients”. Journal of Uludağ University Medical Faculty, vol. 29, no. 2, June 2003, pp. 1-6, https://izlik.org/JA26UB53UY.
Vancouver
1.Tülay Özçelik, Rıdvan Ali, Fahir Özkalemkaş, Vildan Özkocaman, Ülkü Ozan, Hülya Öztürk, Ahmet Tunalı. Evaluation of Angiogenesis in Acute Leukemia Patients. Journal of Uludağ University Medical Faculty [Internet]. 2003 Jun. 1;29(2):1-6. Available from: https://izlik.org/JA26UB53UY

ISSN: 1300-414X, e-ISSN: 2645-9027

Creative Commons License
Journal of Uludag University Medical Faculty is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
2023